AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
COST-EFFECTIVENESS OF MULTI-THERAPY TREATMENT STRATEGIES IN THE PREVENTION OF VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Authors: ROSNER AJ GRIMA DT TORRANCE GW BRADLEY C ADACHI JD SEBALDT RJ WILLISON DJ
Citation: Aj. Rosner et al., COST-EFFECTIVENESS OF MULTI-THERAPY TREATMENT STRATEGIES IN THE PREVENTION OF VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, PharmacoEconomics, 14(5), 1998, pp. 559-573
ADDITION OF BISPHOSPHONATE THERAPY WITH ETIDRONATE OR ALENDRONATE TO STABLE ESTROGEN REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN INCREASES LUMBAR SPINE AND FEMORAL TROCHANTER BONE-MINERAL DENSITY
Authors: SEBALDT RJ ADACHI JD GORDON M PETRIE A GOLDSMITH CH
Citation: Rj. Sebaldt et al., ADDITION OF BISPHOSPHONATE THERAPY WITH ETIDRONATE OR ALENDRONATE TO STABLE ESTROGEN REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN INCREASES LUMBAR SPINE AND FEMORAL TROCHANTER BONE-MINERAL DENSITY, Arthritis and rheumatism, 41(9), 1998, pp. 68-68
THE EFFECT OF ETIDRONATE ON LUMBAR SPINE BONE-MINERAL DENSITY IN MEN
Authors: SEBALDT RJ ADACHI JD BORATTO M GORDON M STEELE M STEPHENSON GF GOLDSMITH CH
Citation: Rj. Sebaldt et al., THE EFFECT OF ETIDRONATE ON LUMBAR SPINE BONE-MINERAL DENSITY IN MEN, Arthritis and rheumatism, 41(9), 1998, pp. 69-69
INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 3 YEARS OF FOLLOW-UP
Authors: SEBALDT RJ ADACHI JD BORATTO M GORDON M STEELE M STEPHENSON GF GOLDSMITH CH
Citation: Rj. Sebaldt et al., INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 3 YEARS OF FOLLOW-UP, Arthritis and rheumatism, 41(9), 1998, pp. 1617-1617
COMPARISON OF BMD MEASUREMENTS AT 6 AND 12 MONTHS IN ASSESSING RESPONSE TO ETIDRONATE IN OSTEOPOROSIS
Authors: CRILLY R SEBALDT RJ ADACHI JD BROWN JP HANLEY DA OLSZYNSKI WP PETRIE A STEMARIE LG HODSMAN AB
Citation: R. Crilly et al., COMPARISON OF BMD MEASUREMENTS AT 6 AND 12 MONTHS IN ASSESSING RESPONSE TO ETIDRONATE IN OSTEOPOROSIS, Journal of bone and mineral research, 12, 1997, pp. 486-486
INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 3 YEARS OF FOLLOW-UP
Authors: SEBALDT RJ ADACHI JD GORDON M STEELE M PETRIE A GOLDSMITH C
Citation: Rj. Sebaldt et al., INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 3 YEARS OF FOLLOW-UP, Journal of bone and mineral research, 12, 1997, pp. 630-630
FLUORIDE THERAPY IN THE PREVENTION OF RHEUMATOID-ARTHRITIS INDUCED BONE LOSS
Authors: IOANNIDIS G ADACHI JD BELL MJ BENSEN WG BIANCHI F CIVIDINO A SEBALDT RJ GORDON M GOLDSMITH C
Citation: G. Ioannidis et al., FLUORIDE THERAPY IN THE PREVENTION OF RHEUMATOID-ARTHRITIS INDUCED BONE LOSS, Journal of bone and mineral research, 12, 1997, pp. 641-641
INTERMITTENT CYCLICAL ETIDRONATE THERAPY FOR THE PREVENTION OF RHEUMATOID-ARTHRITIS INDUCED BONE LOSS FOLLOWING 18 MONTHS OF FLUORIDE THERAPY OR PLACEBO
Authors: IOANNIDIS G ADACHI JD BENSEN WG BIANCHI F CIVIDINO A SEBALDT RJ GORDON M GOLDSMITH C
Citation: G. Ioannidis et al., INTERMITTENT CYCLICAL ETIDRONATE THERAPY FOR THE PREVENTION OF RHEUMATOID-ARTHRITIS INDUCED BONE LOSS FOLLOWING 18 MONTHS OF FLUORIDE THERAPY OR PLACEBO, Journal of bone and mineral research, 12, 1997, pp. 642-642
FLUORIDE THERAPY IN PREVENTION OF RHEUMATOID-ARTHRITIS INDUCED BONE LOSS
Authors: ADACHI JD BELL MJ BENSEN WG BIANCHI F CIVIDINO A SEBALDT RJ GORDON M IOANNIDIS G GOLDSMITH C
Citation: Jd. Adachi et al., FLUORIDE THERAPY IN PREVENTION OF RHEUMATOID-ARTHRITIS INDUCED BONE LOSS, Journal of rheumatology, 24(12), 1997, pp. 2308-2313
SALMON-CALCITONIN NASAL SPRAY IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS
Authors: ADACHI JD BENSEN WG BELL MJ BIANCHI FA CIVIDINO AA CRAIG GL STURTRIDGE WC SEBALDT RJ STEELE M GORDON M THEMELES E TUGWELL P ROBERTS R GENT M
Citation: Jd. Adachi et al., SALMON-CALCITONIN NASAL SPRAY IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS, British journal of rheumatology, 36(2), 1997, pp. 255-259
INFORMATION TECHNOLOGY AND THE FUTURE OF MEDICAL-EDUCATION
Authors: SEBALDT RJ
Citation: Rj. Sebaldt, INFORMATION TECHNOLOGY AND THE FUTURE OF MEDICAL-EDUCATION, Clinical and investigative medicine, 20(6), 1997, pp. 419-421
FORMATION OF SN-1,2-DIRADYLGLYCEROL FOLLOWING EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ETHYL-ESTER SUPPLEMENTATION IN-VIVO
Authors: MARIGNANI PA SEBALDT RJ
Citation: Pa. Marignani et Rj. Sebaldt, FORMATION OF SN-1,2-DIRADYLGLYCEROL FOLLOWING EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ETHYL-ESTER SUPPLEMENTATION IN-VIVO, The FASEB journal, 10(3), 1996, pp. 4171-4171
COMPARISON OF ETIDRONATE AND ESTROGEN - EFFECTS ON LUMBAR SPINAL BONE-MINERAL DENSITY CHANGE AND VERTEBRAL FRACTURE RATE
Authors: SEBALDT RJ ADACHI JD GORDON M STEELE M BORATTO M GOLDSMITH CH
Citation: Rj. Sebaldt et al., COMPARISON OF ETIDRONATE AND ESTROGEN - EFFECTS ON LUMBAR SPINAL BONE-MINERAL DENSITY CHANGE AND VERTEBRAL FRACTURE RATE, Journal of bone and mineral research, 11, 1996, pp. 652-652
N-3 POLYUNSATURATED FATTY ACID-INDUCED CHANGES IN THE MOLECULAR-SPECIES COMPOSITION OF DIRADYLGLYCEROL IN MURINE PERITONEAL-MACROPHAGES REMAIN STABLE DURING INCUBATION EX-VIVO
Authors: MARIGNANI PA SEBALDT RJ
Citation: Pa. Marignani et Rj. Sebaldt, N-3 POLYUNSATURATED FATTY ACID-INDUCED CHANGES IN THE MOLECULAR-SPECIES COMPOSITION OF DIRADYLGLYCEROL IN MURINE PERITONEAL-MACROPHAGES REMAIN STABLE DURING INCUBATION EX-VIVO, Lipids, 31(7), 1996, pp. 771-776
THE FORMATION OF DIRADYLGLYCEROL MOLECULAR-SPECIES IN MURINE PERITONEAL-MACROPHAGES VARIES DOSE-DEPENDENTLY WITH DIETARY PURIFIED EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ETHYL-ESTERS
Authors: MARIGNANI PA SEBALDT RJ
Citation: Pa. Marignani et Rj. Sebaldt, THE FORMATION OF DIRADYLGLYCEROL MOLECULAR-SPECIES IN MURINE PERITONEAL-MACROPHAGES VARIES DOSE-DEPENDENTLY WITH DIETARY PURIFIED EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ETHYL-ESTERS, The Journal of nutrition, 126(11), 1996, pp. 2738-2745
MOLECULAR-SPECIES FRACTIONATION OF DIRADYLGLYCEROL (VOL 125, PG 3030,1995)
Authors: MARIGNANI PA SEBALDT RJ
Citation: Pa. Marignani et Rj. Sebaldt, MOLECULAR-SPECIES FRACTIONATION OF DIRADYLGLYCEROL (VOL 125, PG 3030,1995), The Journal of nutrition, 126(11), 1996, pp. 2943-2943
ACYL-CHAIN DEPENDENCE OF DIACYLGLYCEROL ACTIVATION OF PROTEIN-KINASE-C ACTIVITY IN-VITRO
Authors: MARIGNANI PA EPAND RM SEBALDT RJ
Citation: Pa. Marignani et al., ACYL-CHAIN DEPENDENCE OF DIACYLGLYCEROL ACTIVATION OF PROTEIN-KINASE-C ACTIVITY IN-VITRO, Biochemical and biophysical research communications, 225(2), 1996, pp. 469-473
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE EFFECTS OF FLUORIDE ON LUMBAR SPINE BONE-MINERAL DENSITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: ADACHI JD BELL MJ BENSEN WG BIANCHI F CIVIDINO A KAMINSKA E SCOCCHIA T SEBALDT RJ GORDON M GOLDSMITH CH
Citation: Jd. Adachi et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE EFFECTS OF FLUORIDE ON LUMBAR SPINE BONE-MINERAL DENSITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 39(9), 1996, pp. 661-661
2ND MESSENGER DIRADYLGLYCEROL FORMATION IN MURINE PERITONEAL-MACROPHAGES IS ALTERED FOLLOWING IN-VIVO N-3 FATTY-ACID SUPPLEMENTATION - QUANTITATIVE AND MOLECULAR-SPECIES DETERMINATION
Authors: MARIGNANI PA SEBALDT RJ
Citation: Pa. Marignani et Rj. Sebaldt, 2ND MESSENGER DIRADYLGLYCEROL FORMATION IN MURINE PERITONEAL-MACROPHAGES IS ALTERED FOLLOWING IN-VIVO N-3 FATTY-ACID SUPPLEMENTATION - QUANTITATIVE AND MOLECULAR-SPECIES DETERMINATION, The FASEB journal, 9(3), 1995, pp. 441-441
WILLINGNESS TO INITIATE HORMONE REPLACEMENT THERAPY FOR PREVENTION ORTREATMENT OF OSTEOPOROSIS - IDENTIFICATION OF PATIENT SUBSETS
Authors: SEBALDT RJ ADACHI JD GORDON M STEELE M
Citation: Rj. Sebaldt et al., WILLINGNESS TO INITIATE HORMONE REPLACEMENT THERAPY FOR PREVENTION ORTREATMENT OF OSTEOPOROSIS - IDENTIFICATION OF PATIENT SUBSETS, Journal of bone and mineral research, 10, 1995, pp. 252-252
INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP
Authors: SEBALDT RJ ADACHI JD BENSEN WG BIANCHI F CIVIDINO A KAMINSKA E GORDON M STEELE M GOLDSMITH C
Citation: Rj. Sebaldt et al., INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP, Journal of bone and mineral research, 10, 1995, pp. 253-253
FORMATION OF 2ND-MESSENGER DIRADYLGLYCEROL IN MURINE PERITONEAL-MACROPHAGES IS ALTERED AFTER IN-VIVO (N-3) POLYUNSATURATED FATTY-ACID SUPPLEMENTATION
Authors: MARIGNANI PA SEBALDT RJ
Citation: Pa. Marignani et Rj. Sebaldt, FORMATION OF 2ND-MESSENGER DIRADYLGLYCEROL IN MURINE PERITONEAL-MACROPHAGES IS ALTERED AFTER IN-VIVO (N-3) POLYUNSATURATED FATTY-ACID SUPPLEMENTATION, The Journal of nutrition, 125(12), 1995, pp. 3030-3040
INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP
Authors: ADACHI JD SEBALDT RJ BIANCHI F CIVIDINO A GRAIG GL CRANNEY A KAMINSKA E GORDON M STEELE M GOLDSMITH C
Citation: Jd. Adachi et al., INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP, Arthritis and rheumatism, 38(6), 1995, pp. 34-34
INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS
Authors: ADACHI JD CRANNEY A GOLDSMITH CH BENSEN WG BIANCHI F CIVIDINO A CRAIG GL KAMINSKA E SEBALDT RJ PAPAIOANNOU A BORATTO M GORDON M STEELE M
Citation: Jd. Adachi et al., INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS, Journal of rheumatology, 21(10), 1994, pp. 1922-1926
INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS
Authors: ADACHI JD BENSEN WG BIANCHI F CIVIDINO A CRAIG GL CRANNEY A KAMINSKA E PAPAIOANNOU A SEBALDT RJ BORRATTO M GORDON M STEELE M GOLDSMITH C
Citation: Jd. Adachi et al., INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS, Journal of bone and mineral research, 8, 1993, pp. 190000325-190000325
Risultati: 1-25 | 26-31